Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» APTO-253
APTO-253
Three years later the FDA finally lifts its hold on Aptose drug, setting the stage for a return to PhIb
Endpoints
Fri, 06/29/18 - 10:03 am
Aptose Biosciences
clinical trials
APTO-253